Eczema Therapeutics Market- Roadmap for Recovery from COVID-19 | Geopolitical Uncertainties to Boost the Market Growth | Tech...
25 Septiembre 2020 - 8:00PM
Business Wire
Technavio has been monitoring the eczema therapeutics market and
it is poised to grow by USD 3.60 bn during 2020-2024, progressing
at a CAGR of over 9% during the forecast period. The report offers
an up-to-date analysis regarding the current market scenario,
latest trends and drivers, and the overall market environment.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200925005337/en/
Technavio has announced its latest market
research report titled Global Eczema Therapeutics Market 2020-2024
(Graphic: Business Wire)
Although the COVID-19 pandemic continues to transform the growth
of various industries, the immediate impact of the outbreak is
varied. While a few industries will register a drop in demand,
numerous others will continue to remain unscathed and show
promising growth opportunities. Technavio’s in-depth research has
all your needs covered as our research reports include all
foreseeable market scenarios, including pre- & post-COVID-19
analysis. Download a Free Sample Report on COVID-19 Impacts
Frequently Asked Questions:
- What are the major trends in the market? Increasing healthcare
expenditure is a major trend driving the growth of the market.
- At what rate is the market projected to grow? The
year-over-year growth for 2020 is estimated at 7.09% and the
incremental growth of the market is anticipated to be $ 3.60
bn.
- Who are the top players in the market? AbbVie Inc., Alliance
Pharma Plc., Bausch Health Companies Inc., Bayer AG, Eli Lilly and
Co., Encore Dermatology Inc., LEO Pharma AS, Mylan NV, Pfizer Inc.,
and Sanofi are some of the major market participants.
- What are the key market drivers? The geopolitical uncertainties
is one of the major factors driving the market.
- How big is the North America market? The North America region
will contribute 41% of the market share.
The market is fragmented, and the degree of fragmentation will
accelerate during the forecast period. AbbVie Inc., Alliance Pharma
Plc., Bausch Health Companies Inc., Bayer AG, Eli Lilly and Co.,
Encore Dermatology Inc., LEO Pharma AS, Mylan NV, Pfizer Inc., and
Sanofi are some of the major market participants. The geopolitical
uncertainties will offer immense growth opportunities. To make most
of the opportunities, market vendors should focus more on the
growth prospects in the fast-growing segments, while maintaining
their positions in the slow-growing segments.
Buy 1 Technavio report and get the second for
50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot
before purchasing
Technavio's custom research reports offer detailed insights
on the impact of COVID-19 at an industry level, a regional level,
and subsequent supply chain operations. This customized report will
also help clients keep up with new product launches in direct &
indirect COVID-19 related markets, upcoming vaccines and pipeline
analysis, and significant developments in vendor operations and
government regulations.
Eczema Therapeutics Market 2020-2024: Segmentation
Eczema Therapeutics Market is segmented as below:
- Indication
- Atopic Dermatitis
- Contact Dermatitis
- Other Indication
- Geographic Landscape
- Asia
- Europe
- North America
- ROW
To learn more about the global trends impacting the future of
market research, download a free sample:
https://www.technavio.com/talk-to-us?report=IRTNTR40707
Eczema Therapeutics Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way
of study, synthesis, and summation of data from multiple sources.
The eczema therapeutics market report covers the following
areas:
- Eczema Therapeutics Market Size
- Eczema Therapeutics Market Trends
- Eczema Therapeutics Market Industry Analysis
This study identifies increasing healthcare expenditure as one
of the prime reasons driving the eczema therapeutics market growth
during the next few years.
Technavio suggests three forecast scenarios (optimistic,
probable, and pessimistic) considering the impact of COVID-19.
Technavio’s in-depth research has direct and indirect COVID-19
impacted market research reports. Register for a free trial today
and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Eczema Therapeutics Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist eczema
therapeutics market growth during the next five years
- Estimation of the eczema therapeutics market size and its
contribution to the parent market
- Predictions on upcoming trends and changes in consumer
behavior
- The growth of the eczema therapeutics market
- Analysis of the market’s competitive landscape and detailed
information on vendors
- Comprehensive details of factors that will challenge the growth
of eczema therapeutics market vendors
Table of Contents:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Value chain analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: CUSTOMER LANDSCAPE
PART 07: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 08: MARKET SEGMENTATION BY INDICATION
- Market segmentation by indication
- Comparison by indication
- Atopic dermatitis - Market size and forecast 2019-2024
- Contact dermatitis - Market size and forecast 2019-2024
- Other indication - Market size and forecast 2019-2024
- Market opportunity by indication
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Business strategies
- Geopolitical uncertainties
- Increasing healthcare expenditure
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- AbbVie Inc.
- Alliance Pharma Plc
- Bausch Health Companies, Inc.
- Bayer AG
- Eli Lilly and Co.
- Encore Dermatology Inc.
- LEO Pharma AS
- Mylan NV
- Pfizer Inc.
- Sanofi
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
About Us
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions. With over 500 specialized analysts,
Technavio’s report library consists of more than 17,000 reports and
counting, covering 800 technologies, spanning across 50 countries.
Their client base consists of enterprises of all sizes, including
more than 100 Fortune 500 companies. This growing client base
relies on Technavio’s comprehensive coverage, extensive research,
and actionable market insights to identify opportunities in
existing and potential markets and assess their competitive
positions within changing market scenarios.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200925005337/en/
Technavio Research Jesse Maida Media & Marketing Executive
US: +1 844 364 1100 UK: +44 203 893 3200 Email: media@technavio.com
Website: www.technavio.com/